Amneal appoints gustavo pesquin as executive vice president, chief commercial officer – specialty

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) today announced it has appointed gustavo pesquin as executive vice president, chief commercial officer - specialty, effective september 6, 2022. mr. pesquin joins the company from sanofi, a global pharmaceutical company, where he served leadership roles of increasing responsibility over his 11-year tenure, including most recently as north america head for general medicines. prior to that, m
AMRX Ratings Summary
AMRX Quant Ranking